dibenz[a,h]anthracene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	dibenz[a,h]anthracene	go back to main search page
Accession:	CHEBI:35299	browse the term
Definition:	An ortho-fused polycyclic arene that has formula C22H14.
Synonyms:	related_synonym:	1,2:5,6-Dibenzanthracene; DBA; Formula=C22H14; InChI=1S/C22H14/c1-3-7-19-15(5-1)9-11-17-14-22-18(13-21(17)19)12-10-16-6-2-4-8-20(16)22/h1-14H; InChIKey=LHRCREOYAASXPZ-UHFFFAOYSA-N; SMILES=c1ccc2c(c1)ccc1cc3c(ccc4ccccc34)cc21
	alt_id:	CHEBI:18901; CHEBI:34684
	xref:	CAS:53-70-3; KEGG:C14325
	xref_mesh:	MESH:C026486

show annotations for term's descendants Sort by:
Rat (841) Mouse (896) Human (848) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (896)

dibenz[a,h]anthracene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA

NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186

G

alanine and arginine rich domain containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AARD mRNA

NCBI chr15:51,903,503...51,909,118
Ensembl chr15:51,903,503...51,909,118

G

ATP-binding cassette, sub-family A member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCA1 mRNA

NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895

G

ATP-binding cassette, sub-family A member 8a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCA8A mRNA

NCBI chr11:109,916,460...109,988,403
Ensembl chr11:109,916,460...109,986,804

G

ATP-binding cassette, sub-family B member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1A mRNA

NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575

G

ATP-binding cassette, sub-family B member 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1B mRNA

NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315

G

ATP-binding cassette, sub-family B member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB4 mRNA

NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231

G

ATP-binding cassette, sub-family C member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABCC3 mRNA

NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823

G

ATP-binding cassette, sub-family D member 3

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA

NCBI chr 3:121,552,553...121,609,851
Ensembl chr 3:121,552,423...121,608,951

G

ATP binding cassette subfamily G member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCG5 mRNA

NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439

G

abhydrolase domain containing 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD15 mRNA

NCBI chr11:77,405,943...77,411,454
Ensembl chr11:77,405,947...77,429,433

G

abhydrolase domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD5 mRNA

NCBI chr 9:122,180,681...122,210,589
Ensembl chr 9:122,180,673...122,210,589

G

ABI family member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABI3 mRNA

NCBI chr11:95,720,898...95,733,302
Ensembl chr11:95,720,900...95,733,302

G

ABI family member 3 binding protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABI3BP mRNA

NCBI chr16:56,298,179...56,510,498
Ensembl chr16:56,298,241...56,510,498

G

actin-binding LIM protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABLIM1 mRNA

NCBI chr19:57,021,165...57,303,776
Ensembl chr19:57,021,165...57,303,351

G

atypical chemokine receptor 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACKR4 mRNA

NCBI chr 9:103,974,881...104,003,842
Ensembl chr 9:103,961,356...104,004,132

G

acyl-CoA thioesterase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOT1 mRNA

NCBI chr12:84,056,276...84,064,444
Ensembl chr12:84,056,264...84,065,145

G

acyl-Coenzyme A oxidase 2, branched chain

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ACOX2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ACOX2 mRNA

NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262

G

acyl-Coenzyme A oxidase-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOXL mRNA

NCBI chr 2:127,680,717...127,968,172
Ensembl chr 2:127,680,796...127,965,793

G

activin receptor IIB

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ACVR2B mRNA

NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061

G

ADAM metallopeptidase domain 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAM15 mRNA

NCBI chr 3:89,246,947...89,257,589
Ensembl chr 3:89,245,849...89,257,303

G

ADAM-like, decysin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMDEC1 mRNA

NCBI chr14:68,800,829...68,819,535
Ensembl chr14:68,800,829...68,819,544

G

ADAMTS-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMTSL2 mRNA

NCBI chr 2:26,969,348...26,998,993
Ensembl chr 2:26,969,391...26,998,993

G

adenosine deaminase, tRNA-specific 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADAT3 mRNA

NCBI chr10:80,438,714...80,443,488
Ensembl chr10:80,441,855...80,451,618
Ensembl chr10:80,441,855...80,451,618

G

adhesion G protein-coupled receptor L4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADGRL4 mRNA

NCBI chr 3:151,143,519...151,250,718
Ensembl chr 3:151,143,524...151,250,723

G

adrenomedullin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADM mRNA

NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027

G

ADP-ribosylarginine hydrolase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADPRH mRNA

NCBI chr16:38,265,761...38,273,051
Ensembl chr16:38,264,392...38,273,065

G

adrenergic receptor, beta 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB1 mRNA

NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545

G

adrenergic receptor, beta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB2 mRNA

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

apoptosis enhancing nuclease

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AEN mRNA

NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957

G

AFG1 like ATPase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AFG1L mRNA

NCBI chr10:42,188,577...42,354,561
Ensembl chr10:42,188,581...42,354,561

G

angiotensin II receptor, type 1a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AGTR1A mRNA

NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850

G

S-adenosylhomocysteine hydrolase-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AHCYL2 mRNA

NCBI chr 6:29,768,378...29,912,309
Ensembl chr 6:29,768,010...29,912,309

G

aryl-hydrocarbon receptor

affects response to substance
increases activity
multiple interactions
affects binding
affects localization

AHR affects the susceptibility to 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene results in increased activity of AHR protein
1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
1,2,5,6-dibenzanthracene binds to AHR protein
1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene affects the localization of AHR protein]
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene binds to AHR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]

PMID:3005314 PMID:3011254 PMID:3024361 PMID:6322977 PMID:11525907 More...

NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037

G

aryl-hydrocarbon receptor repressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AHRR mRNA

NCBI chr13:74,359,237...74,440,450
Ensembl chr13:74,359,237...74,440,450

G

apoptosis-inducing factor, mitochondrion-associated 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA

NCBI chr10:61,551,042...61,575,474
Ensembl chr10:61,551,042...61,575,039

G

adenylate kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK1 mRNA

NCBI chr 2:32,511,770...32,525,070
Ensembl chr 2:32,511,770...32,525,070

G

adenylate kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK4 mRNA

NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192

G

aldo-keto reductase family 1 member B

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA

PMID:17690111 PMID:18711122

NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413

G

aldolase B, fructose-bisphosphate

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ALDOB mRNA

NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546

G

alkaline phosphatase, liver/bone/kidney

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALPL mRNA

NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695

G

alsin Rho guanine nucleotide exchange factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALS2 mRNA

NCBI chr 1:59,201,915...59,276,390
Ensembl chr 1:59,202,085...59,276,390

G

alpha-methylacyl-CoA racemase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AMACR mRNA

NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712

G

anillin, actin binding protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ANLN mRNA

NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484

G

annexin A8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ANXA8 mRNA

NCBI chr14:33,807,936...33,822,528
Ensembl chr14:33,807,938...33,822,528

G

apolipoprotein C-III

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of APOC3 mRNA

NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934

G

apolipoprotein D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of APOD mRNA

NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626

G

adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of APPL1 mRNA

NCBI chr14:26,640,943...26,692,567
Ensembl chr14:26,640,945...26,693,189

G

aquaporin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AQP1 mRNA

NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540

G

androgen receptor

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of AR protein
1,2,5,6-dibenzanthracene affects the reaction [Androgens results in increased activity of AR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AR protein

PMID:10771140 PMID:28377212 PMID:28803809

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

arginine and glutamate rich 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARGLU1 mRNA

NCBI chr 8:8,716,307...8,741,818
Ensembl chr 8:8,715,075...8,740,521

G

Rho GTPase activating protein 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGAP26 mRNA

NCBI chr18:38,734,531...39,509,338
Ensembl chr18:39,126,198...39,509,337
Ensembl chr18:39,126,198...39,509,337

G

Rho guanine nucleotide exchange factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGEF26 mRNA

NCBI chr 3:62,244,946...62,369,642
Ensembl chr 3:62,245,765...62,369,642

G

ADP-ribosylation factor-like 4A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4A mRNA

NCBI chr12:40,083,290...40,087,986
Ensembl chr12:40,055,446...40,088,024

G

ADP-ribosylation factor-like 4D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4D mRNA

NCBI chr11:101,556,367...101,558,658
Ensembl chr11:101,556,367...101,558,658

G

armadillo repeat containing, X-linked 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARMCX4 mRNA

NCBI chr X:133,586,399...133,598,524
Ensembl chr X:133,587,268...133,597,506

G

arrestin domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARRDC4 mRNA

NCBI chr 7:68,386,742...68,398,986
Ensembl chr 7:68,386,743...68,398,989

G

arylsulfatase G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARSG mRNA

NCBI chr11:109,364,159...109,464,156
Ensembl chr11:109,364,200...109,464,156

G

ADP-ribosyltransferase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART3 mRNA

NCBI chr 5:92,479,659...92,562,487
Ensembl chr 5:92,479,686...92,562,487

G

ADP-ribosyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART4 mRNA

NCBI chr 6:136,825,449...136,834,598
Ensembl chr 6:136,825,449...136,834,731

G

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA

NCBI chr12:21,161,369...21,320,172
Ensembl chr12:21,040,460...21,320,172

G

anti-silencing function 1B histone chaperone

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA

NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826

G

asialoglycoprotein receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASGR1 mRNA

NCBI chr11:69,939,735...69,948,721
Ensembl chr11:69,944,911...69,948,720

G

asparagine synthetase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASNS mRNA

NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254

G

aspartoacylase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPA mRNA

NCBI chr11:73,195,813...73,217,677
Ensembl chr11:73,195,818...73,220,422

G

abnormal spindle microtubule assembly

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPM mRNA

NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829

G

activating transcription factor 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ATF3 mRNA

NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236

G

activating transcription factor 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ATF5 mRNA

NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082

G

autophagy related 4C, cysteine peptidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATG4C mRNA

NCBI chr 4:99,077,181...99,185,495
Ensembl chr 4:99,082,171...99,148,024

G

ATPase, Na+/K+ transporting, alpha 2 polypeptide

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATP1A2 mRNA

NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631

G

ATPase, class I, type 8B, member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATP8B5 mRNA

NCBI chr 4:43,266,716...43,373,831
Ensembl chr 4:43,267,159...43,373,833

G

aurora kinase A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AURKA mRNA

NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455

G

arginine vasopressin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AVPR1A mRNA

NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357

G

beta-site APP-cleaving enzyme 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BACE2 mRNA

NCBI chr16:97,157,928...97,244,136
Ensembl chr16:97,157,942...97,244,136

G

BCL2-associated athanogene 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BAG3 mRNA

NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705

G

brain-specific angiogenesis inhibitor 1-associated protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAIAP2 mRNA

NCBI chr11:119,833,762...119,897,608
Ensembl chr11:119,833,589...119,897,608

G

basic leucine zipper transcription factor, ATF-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA

NCBI chr12:85,733,494...85,755,861
Ensembl chr12:85,733,443...85,755,861

G

BCL2-associated X protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAX mRNA

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

BCL2 binding component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BBC3 mRNA

NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130

G

brevican

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCAN mRNA

NCBI chr 3:87,894,839...87,908,458
Ensembl chr 3:87,894,838...87,907,537

G

BCL2-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL2L1 mRNA

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

B cell leukemia/lymphoma 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA

NCBI chr 7:19,542,387...19,556,691
Ensembl chr 7:19,542,387...19,556,695

G

B cell leukemia/lymphoma 6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL6 mRNA

NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602

G

B cell CLL/lymphoma 6, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL6B mRNA

NCBI chr11:70,114,953...70,120,624
Ensembl chr11:70,114,954...70,120,624

G

B cell CLL/lymphoma 7C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL7C mRNA

NCBI chr 7:127,260,626...127,307,938
Ensembl chr 7:127,260,628...127,308,105

G

brain expressed, associated with Nedd4, 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BEAN1 mRNA

NCBI chr 8:104,897,110...104,945,730
Ensembl chr 8:104,897,074...104,945,754

G

basic helix-loop-helix family, member e40

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BHLHE40 mRNA

NCBI chr 6:108,637,590...108,643,886
Ensembl chr 6:108,637,590...108,643,886

G

bridging integrator 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BIN2 mRNA

NCBI chr15:100,538,963...100,567,384
Ensembl chr15:100,538,958...100,567,434

G

baculoviral IAP repeat-containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BIRC5 mRNA

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

basic helix-loop-helix ARNT like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMAL1 mRNA

NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333

G

bone morphogenetic protein receptor, type 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMPR1B mRNA

NCBI chr 3:141,540,230...141,875,335
Ensembl chr 3:141,542,897...141,875,186

G

BCL2/adenovirus E1B interacting protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BNIP3 mRNA

NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248

G

BCL2-related ovarian killer

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BOK mRNA

NCBI chr 1:93,613,297...93,623,492
Ensembl chr 1:93,613,382...93,623,486

G

bone marrow stromal cell antigen 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BST2 mRNA

NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100

G

BTG anti-proliferation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BTG1 mRNA

NCBI chr10:96,452,863...96,458,675
Ensembl chr10:96,452,868...96,458,671

G

complement component 1, q subcomponent, beta polypeptide

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of C1QB mRNA

NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498

G

C1q and tumor necrosis factor related protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF2 mRNA

NCBI chr11:43,364,984...43,382,485
Ensembl chr11:43,365,103...43,382,352

G

C1q and tumor necrosis factor related protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF5 mRNA

NCBI chr 9:44,013,067...44,020,484
Ensembl chr 9:44,018,542...44,020,484

G

C1q and tumor necrosis factor related protein 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF7 mRNA

NCBI chr 5:43,672,792...43,776,805
Ensembl chr 5:43,672,881...43,776,145

G

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAD mRNA

NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823

G

calcitonin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CALCR mRNA

NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714

G

calpain 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPN8 mRNA

NCBI chr 1:182,392,314...182,462,021
Ensembl chr 1:182,392,572...182,459,917

G

cell cycle associated protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA

NCBI chr 2:103,593,292...103,627,946
Ensembl chr 2:103,593,286...103,627,994

G

carbonic anhydrase 3

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CA3 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CAR3 mRNA

PMID:17690111 PMID:26377693

NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583

G

carbonic anhydrase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CAR8 mRNA

NCBI chr 4:8,141,491...8,239,226
Ensembl chr 4:8,143,362...8,239,041

G

calcium regulated heat stable protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CARHSP1 mRNA

NCBI chr16:8,476,444...8,490,017
Ensembl chr16:8,476,444...8,490,019

G

caspase 3

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP3 protein

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 7

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP7 protein

NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776

G

coiled-coil domain containing 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCDC162 mRNA

NCBI chr10:41,414,838...41,592,586
Ensembl chr10:41,414,842...41,592,630

G

coiled-coil domain containing 184

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCDC184 mRNA

NCBI chr15:98,065,687...98,068,015
Ensembl chr15:98,065,039...98,068,015

G

C-C motif chemokine ligand 19

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCL19 mRNA

NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577

G

cerebral cavernous malformation 2-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCM2L mRNA

NCBI chr 2:152,907,857...152,923,655
Ensembl chr 2:152,907,875...152,923,655

G

cellular communication network factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN1 mRNA

NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736

G

cellular communication network factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN2 mRNA

NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581

G

cellular communication network factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN4 mRNA

NCBI chr15:66,763,337...66,795,050
Ensembl chr15:66,763,169...66,795,050

G

cellular communication network factor 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN5 mRNA

NCBI chr 2:163,662,724...163,675,066
Ensembl chr 2:163,662,781...163,675,066

G

cyclin A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNA2 mRNA

NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299

G

cyclin B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNB1 mRNA

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

cyclin B2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNB2 mRNA

NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829

G

cyclin D1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCND1 mRNA

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cyclin F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNF mRNA

NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458

G

cyclin G1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNG1 mRNA

NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138

G

cyclin J-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNJL mRNA

NCBI chr11:43,419,576...43,477,826
Ensembl chr11:43,419,611...43,477,824

G

C-C motif chemokine receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CCR2 mRNA

NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594

G

CD151 antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD151 mRNA

NCBI chr 7:141,047,275...141,051,394
Ensembl chr 7:141,047,305...141,051,386

G

CD1d1 antigen

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD1D1 mRNA

NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748

G

CD200 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD200 mRNA

NCBI chr16:45,202,474...45,229,419
Ensembl chr16:45,202,498...45,229,416

G

CD24a antigen

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD24A mRNA

NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261

G

CD34 antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD34 mRNA

NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587

G

CD38 antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD38 mRNA

NCBI chr 5:44,026,153...44,069,714
Ensembl chr 5:44,025,895...44,069,717

G

CD63 antigen

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD63 protein

NCBI chr10:128,731,577...128,748,691
Ensembl chr10:128,736,858...128,748,691

G

CD81 antigen

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD81 protein

NCBI chr 7:142,606,487...142,621,667
Ensembl chr 7:142,606,476...142,621,671

G

cell division cycle 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDC20 mRNA

NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549

G

cell division cycle associated 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA5 mRNA

NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807

G

cell division cycle associated 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA8 mRNA

NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104

G

cadherin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CDH1 mRNA

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cadherin 17

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CDH17 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA

NCBI chr 4:11,758,157...11,817,905
Ensembl chr 4:11,758,147...11,817,895

G

cyclin dependent kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDK1 mRNA

NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768

G

cyclin dependent kinase inhibitor 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN1A mRNA

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

cyclin dependent kinase inhibitor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN3 mRNA

NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126

G

chromatin licensing and DNA replication factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDT1 mRNA

NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293

G

CCAAT/enhancer binding protein beta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CEBPB mRNA

NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338

G

CUGBP, Elav-like family member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CELF5 mRNA

NCBI chr10:81,295,061...81,318,564
Ensembl chr10:81,295,061...81,318,543

G

cell migration inducing hyaluronidase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CEMIP2 mRNA

NCBI chr19:21,755,704...21,835,724
Ensembl chr19:21,755,706...21,835,724

G

centromere protein E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPE mRNA

NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372

G

centromere protein K

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPK mRNA

NCBI chr13:104,365,474...104,386,130
Ensembl chr13:104,365,119...104,388,900

G

carboxyesterase 2B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2B mRNA

NCBI chr 8:105,555,130...105,566,725
Ensembl chr 8:105,558,204...105,566,725

G

carboxylesterase 2E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2E mRNA

NCBI chr 8:105,652,892...105,661,304
Ensembl chr 8:105,652,892...105,661,304

G

carboxylesterase 2G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2G mRNA

NCBI chr 8:105,688,350...105,696,169
Ensembl chr 8:105,688,350...105,696,169

G

carboxylesterase 2H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2 mRNA

NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810

G

cilia and flagella associated protein 69

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFAP69 mRNA

NCBI chr 5:5,629,284...5,714,232
Ensembl chr 5:5,629,278...5,714,239

G

complement factor D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFD mRNA

NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489

G

CASP8 and FADD-like apoptosis regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFLAR mRNA

NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043

G

cell growth regulator with EF hand domain 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CGREF1 mRNA

NCBI chr 5:31,090,487...31,102,771
Ensembl chr 5:31,090,487...31,102,935

G

chromatin assembly factor 1, subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHAF1B mRNA

NCBI chr16:93,680,801...93,703,003
Ensembl chr16:93,680,789...93,703,003

G

chromodomain helicase DNA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHD2 mRNA

NCBI chr 7:73,076,400...73,191,494
Ensembl chr 7:73,076,386...73,191,578

G

choline kinase alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHKA mRNA

NCBI chr19:3,901,585...3,944,368
Ensembl chr19:3,901,773...3,944,369

G

chimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHN2 mRNA

NCBI chr 6:54,016,917...54,278,797
Ensembl chr 6:54,016,539...54,278,795

G

cysteine and histidine rich domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA

NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738

G

carbohydrate sulfotransferase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHST5 mRNA

NCBI chr 8:112,615,767...112,636,831
Ensembl chr 8:112,615,768...112,637,079

G

ciliary microtubule associated protein 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMAP1B mRNA

NCBI chr15:89,261,652...89,263,817
Ensembl chr15:89,261,652...89,263,790

G

ciliary microtubule inner protein 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMIP2B mRNA

NCBI chr 4:43,427,014...43,431,451
Ensembl chr 4:43,427,019...43,429,134

G

cytokine inducible SH2-containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CISH mRNA

NCBI chr 9:107,173,858...107,179,983
Ensembl chr 9:107,173,225...107,179,983

G

cytoskeleton associated protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CKAP2 mRNA

NCBI chr 8:22,658,168...22,675,835
Ensembl chr 8:22,658,176...22,675,835

G

CDC28 protein kinase 1b

affects expression

1,2,5,6-dibenzanthracene affects the expression of CKS1B mRNA

NCBI chr 3:89,322,779...89,325,598
Ensembl chr 3:89,322,779...89,325,690

G

chloride channel, voltage-sensitive 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLCN2 mRNA

NCBI chr16:20,521,185...20,536,496
Ensembl chr16:20,521,714...20,536,496

G

claudin 7

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA

NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711

G

claudin domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLDND1 mRNA

NCBI chr16:58,548,269...58,554,610
Ensembl chr16:58,548,273...58,554,614

G

C-type lectin domain family 1, member a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLEC1A mRNA

NCBI chr 6:129,403,647...129,428,963
Ensembl chr 6:129,401,735...129,428,963

G

C-type lectin domain family 1, member b

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC1B mRNA

NCBI chr 6:129,374,260...129,382,376
Ensembl chr 6:129,374,260...129,386,298

G

C-type lectin domain family 4, member d

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC4D mRNA

NCBI chr 6:123,239,066...123,252,227
Ensembl chr 6:123,239,070...123,252,224

G

calmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLMN mRNA

NCBI chr12:104,729,373...104,831,335
Ensembl chr12:104,729,376...104,831,335

G

clock circadian regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLOCK mRNA

NCBI chr 5:76,357,715...76,452,675
Ensembl chr 5:76,357,715...76,452,639

G

caseinolytic mitochondrial matrix peptidase chaperone subunit

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA

NCBI chr 9:65,201,533...65,237,940
Ensembl chr 9:65,201,542...65,237,940

G

calsyntenin 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLSTN3 mRNA

NCBI chr 6:124,407,715...124,441,743
Ensembl chr 6:124,407,540...124,441,753

G

CKLF-like MARVEL transmembrane domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CMTM4 mRNA

NCBI chr 8:105,074,823...105,122,439
Ensembl chr 8:105,074,823...105,122,439

G

collagen, type IV, alpha 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A1 mRNA

NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826

G

collagen, type IV, alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A2 mRNA

NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287

G

collagen, type V, alpha 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COL5A3 mRNA

NCBI chr 9:20,681,353...20,726,363
Ensembl chr 9:20,681,346...20,726,363

G

collagen like tail subunit of asymmetric acetylcholinesterase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COLQ mRNA

NCBI chr14:31,245,039...31,299,820
Ensembl chr14:31,245,039...31,313,300

G

COMM domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COMMD3 mRNA

NCBI chr 2:18,677,246...18,681,042
Ensembl chr 2:18,677,234...18,681,042

G

coenzyme Q10B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COQ10B mRNA

NCBI chr 1:55,091,929...55,111,861
Ensembl chr 1:55,091,929...55,111,861

G

ceruloplasmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CP mRNA

NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309

G

carboxypeptidase E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPE mRNA

NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088

G

calcineurin-like phosphoesterase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPPED1 mRNA

NCBI chr16:11,621,546...11,727,377
Ensembl chr16:11,621,585...11,727,309

G

ceramide-1-phosphate transfer protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPTP mRNA

NCBI chr 4:155,949,180...155,953,897
Ensembl chr 4:155,949,180...155,953,897

G

cellular retinoic acid binding protein II

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CRABP2 mRNA

NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683

G

cAMP responsive element binding protein-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBL2 mRNA

NCBI chr 6:134,807,090...134,835,894
Ensembl chr 6:134,807,117...134,835,894

G

CREB/ATF bZIP transcription factor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBZF mRNA

NCBI chr 7:90,091,942...90,097,590
Ensembl chr 7:90,091,937...90,097,202

G

cytokine receptor-like factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRLF2 mRNA

NCBI chr 5:109,702,575...109,707,301
Ensembl chr 5:109,702,575...109,706,859

G

carnitine O-octanoyltransferase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CROT mRNA

NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324

G

cryptochrome circadian regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRY2 mRNA

NCBI chr 2:92,233,991...92,264,426
Ensembl chr 2:92,233,991...92,264,388

G

crystallin, mu

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRYM mRNA

NCBI chr 7:119,785,603...119,801,212
Ensembl chr 7:119,785,603...119,801,334

G

colony stimulating factor 1 (macrophage)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CSF1 mRNA

NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785

G

CSA-conditional, T cell activation-dependent protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CSTAD mRNA

NCBI chr 2:30,485,056...30,498,957
Ensembl chr 2:30,485,052...30,498,955

G

catenin delta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CTNND2 mRNA

NCBI chr15:30,172,680...31,029,490
Ensembl chr15:30,172,739...31,029,487

G

cutA divalent cation tolerance homolog-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CUTAL mRNA

NCBI chr 2:34,764,408...34,782,145
Ensembl chr 2:34,764,408...34,782,144

G

C-X3-C motif chemokine ligand 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CX3CL1 mRNA

NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055

G

C-X-C motif chemokine ligand 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CXCL12 mRNA

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine ligand 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CXCL5 mRNA

NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483

G

cytochrome b5 type A (microsomal)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYB5A mRNA

NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression
affects expression
decreases expression
increases activity

[CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein
1,2,5,6-dibenzanthracene affects the expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [dibenzo(a,l)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; dibenzo(a,l)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]
1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; 2-oxohexyl isothiocyanate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; Cadmium Chloride inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
CYP1A1 protein results in increased activity of 1,2,5,6-dibenzanthracene

PMID:8961944 PMID:10190573 PMID:11162773 PMID:11408366 PMID:11955671 More...

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 1, subfamily a, polypeptide 2

multiple interactions
increases expression
decreases activity
increases metabolic processing
increases activity

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA
1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA
1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]

PMID:8638931 PMID:8961944 PMID:11162773 PMID:16269432 PMID:17253728 More...

NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986

G

cytochrome P450, family 1, subfamily b, polypeptide 1

increases expression
increases expression
multiple interactions
affects expression

1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA
dibenz[a,h]anthracene increases expression of CYP1B1 mRNA in lung epithelial cell
1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
1,2,5,6-dibenzanthracene affects the expression of CYP1B1 mRNA

CTD
RGD

PMID:11955671 PMID:12117779 PMID:17253728 PMID:17961608 PMID:19358281 More...

NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP26B1 mRNA

NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890

G

cytochrome P450, family 2, subfamily b, polypeptide 10

multiple interactions
increases metabolic processing

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP2B6 mRNA; [CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol

PMID:8638931 PMID:17690111

NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049

G

cytochrome P450, family 2, subfamily c, polypeptide 65

multiple interactions
increases metabolic processing

[CYP2C9 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol

NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388

G

cytochrome P450, family 2, subfamily d, polypeptide 22

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2D6 mRNA

NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2E1 mRNA

NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900

G

cytochrome P450, family 2, subfamily s, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA

NCBI chr 7:25,501,894...25,515,950
Ensembl chr 7:25,501,900...25,516,338

G

cytochrome P450, family 3, subfamily a, polypeptide 11

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP3A11 mRNA

NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774

G

cytochrome P450, family 7, subfamily b, polypeptide 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP7B1 mRNA

NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502

G

cystin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYS1 mRNA

NCBI chr12:24,715,832...24,731,794
Ensembl chr12:24,715,832...24,731,812

G

cysteine and tyrosine-rich protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYYR1 mRNA

NCBI chr16:85,247,245...85,347,793
Ensembl chr16:85,218,421...85,350,285

G

dachshund family transcription factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DACH1 mRNA

NCBI chr14:98,024,294...98,407,208
Ensembl chr14:98,024,289...98,407,201

G

diazepam binding inhibitor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DBI mRNA

NCBI chr 1:120,041,010...120,048,826
Ensembl chr 1:120,041,010...120,048,808

G

D site albumin promoter binding protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DBP mRNA

NCBI chr 7:45,354,658...45,359,579
Ensembl chr 7:45,354,512...45,359,627

G

DDB1 and CUL4 associated factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCAF4 mRNA

NCBI chr12:83,567,145...83,588,768
Ensembl chr12:83,567,240...83,588,694

G

dachsous cadherin related 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCHS1 mRNA

NCBI chr 7:105,402,196...105,437,562
Ensembl chr 7:105,402,197...105,436,861

G

DNA cross-link repair 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCLRE1A mRNA

NCBI chr19:56,517,593...56,536,716
Ensembl chr19:56,517,599...56,536,675

G

dimethylarginine dimethylaminohydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDAH1 mRNA

NCBI chr 3:145,464,447...145,600,032
Ensembl chr 3:145,464,430...145,600,032

G

DNA damage-induced apoptosis suppressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIAS mRNA

NCBI chr 7:92,506,734...92,523,455
Ensembl chr 7:92,506,733...92,523,455

G

DNA-damage inducible transcript 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DDIT3 mRNA

NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157

G

DNA-damage-inducible transcript 4-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIT4L mRNA

NCBI chr 3:137,329,433...137,334,093
Ensembl chr 3:137,327,373...137,334,094

G

D-aspartate oxidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA

NCBI chr10:40,505,933...40,557,847
Ensembl chr10:40,506,007...40,557,843

G

death effector domain-containing DNA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DEDD2 mRNA

NCBI chr 7:24,899,337...24,920,035
Ensembl chr 7:24,899,340...24,920,040

G

DENN domain containing 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DENND2B mRNA

NCBI chr 7:109,123,118...109,302,828
Ensembl chr 7:109,123,118...109,302,812

G

desumoylating isopeptidase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DESI2 mRNA

NCBI chr 1:178,014,983...178,080,164
Ensembl chr 1:178,014,983...178,084,867

G

desert hedgehog

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DHH mRNA

NCBI chr15:98,779,496...98,796,443
Ensembl chr15:98,789,033...98,796,421

G

dispatched RND transporter family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DISP2 mRNA

NCBI chr 2:118,610,183...118,625,656
Ensembl chr 2:118,610,200...118,641,774

G

dynein, axonemal, heavy chain 7A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAH7A mRNA

NCBI chr 1:53,436,154...53,746,456
Ensembl chr 1:53,436,165...53,745,943

G

dynein axonemal intermediate chain 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI1 mRNA

NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158

G

dynein axonemal intermediate chain 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI4 mRNA

NCBI chr 4:102,891,954...102,971,524
Ensembl chr 4:102,895,262...102,971,752

G

DnaJ heat shock protein family (Hsp40) member A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJA1 mRNA

NCBI chr 4:40,722,468...40,734,965
Ensembl chr 4:40,722,150...40,737,149

G

DnaJ heat shock protein family (Hsp40) member B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA

NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282

G

DNA methyltransferase 3B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNMT3B mRNA

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

deoxynucleotidyltransferase, terminal, interacting protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNTTIP1 mRNA

NCBI chr 2:164,587,935...164,610,140
Ensembl chr 2:164,587,903...164,610,527

G

desmoplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA

NCBI chr13:38,335,357...38,382,553
Ensembl chr13:38,335,270...38,382,553

G

deltex 4, E3 ubiquitin ligase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DTX4 mRNA

NCBI chr19:12,443,700...12,479,509
Ensembl chr19:12,443,702...12,478,818

G

dual specificity phosphatase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of DUSP1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of DUSP1 mRNA

NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102

G

dual-specificity tyrosine phosphorylation regulated kinase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYRK3 mRNA

NCBI chr 1:131,056,178...131,065,991
Ensembl chr 1:131,055,192...131,066,077

G

dysferlin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYSF mRNA

NCBI chr 6:83,985,344...84,188,042
Ensembl chr 6:83,985,572...84,188,042

G

E2F transcription factor 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F7 mRNA

NCBI chr10:110,580,799...110,623,245
Ensembl chr10:110,581,300...110,623,245

G

E2F transcription factor 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F8 mRNA

NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344

G

eosinophil-associated, ribonuclease A family, member 10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EAR10 mRNA

NCBI chr14:44,160,355...44,161,053
Ensembl chr14:44,160,177...44,161,016

G

endothelin converting enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ECE1 mRNA

NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540

G

extracellular matrix protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ECM1 mRNA

NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881

G

endothelin receptor type B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EDNRB mRNA

NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838

G

ephrin A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNA1 mRNA

NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449

G

ephrin B2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNB2 mRNA

NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242

G

early growth response 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EGR1 mRNA

NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037

G

enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of EHHADH mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of EHHADH mRNA

NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557

G

etoposide induced 2.4 mRNA

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EI24 mRNA

NCBI chr 9:36,690,449...36,708,630
Ensembl chr 9:36,690,455...36,708,689

G

endomucin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMCN mRNA

NCBI chr 3:137,046,824...137,136,830
Ensembl chr 3:137,046,828...137,137,946

G

EMI domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMID1 mRNA

NCBI chr11:5,056,265...5,102,322
Ensembl chr11:5,056,265...5,102,257

G

epithelial membrane protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMP1 mRNA

NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171

G

enkurin, TRPC channel interacting protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ENKUR mRNA

NCBI chr 2:21,185,542...21,210,176
Ensembl chr 2:21,185,542...21,210,176

G

erythrocyte membrane protein band 4.1 like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPB41L5 mRNA

NCBI chr 1:119,472,762...119,576,826
Ensembl chr 1:119,472,767...119,576,730

G

Eph receptor A4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPHA4 mRNA

NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725

G

Eph receptor B6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EPHB6 mRNA

NCBI chr 6:41,581,940...41,597,445
Ensembl chr 6:41,582,416...41,597,443

G

epoxide hydrolase 1, microsomal

multiple interactions
increases expression

EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in increased expression of EPHX1 mRNA

PMID:8961944 PMID:26377693

NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469

G

erb-b2 receptor tyrosine kinase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERBB2 mRNA

NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542

G

glutamate rich 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERICH3 mRNA

NCBI chr 3:154,416,770...154,454,649
Ensembl chr 3:154,369,496...154,473,427

G

endothelial cell-specific molecule 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ESM1 mRNA

NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632

G

estrogen related receptor, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ESRRA mRNA

NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208

G

ethylmalonic encephalopathy 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ETHE1 mRNA

NCBI chr 7:24,286,968...24,308,350
Ensembl chr 7:24,286,968...24,308,350

G

eva-1 homolog A, regulator of programmed cell death

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EVA1A mRNA

NCBI chr 6:82,018,058...82,070,079
Ensembl chr 6:82,018,024...82,070,080

G

exocyst complex component 3-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC3L2 mRNA

NCBI chr 7:19,197,212...19,230,687
Ensembl chr 7:19,197,256...19,230,687

G

exocyst complex component 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC4 mRNA

NCBI chr 6:33,226,025...33,950,914
Ensembl chr 6:33,226,020...33,950,914

G

coagulation factor III

increases expression

1,2,5,6-dibenzanthracene results in increased expression of F3 mRNA

NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697

G

fatty acid binding protein 1, liver

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FABP1 mRNA

NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007

G

family with sequence similarity 107, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM107A mRNA

NCBI chr14:14,152,166...14,173,503
Ensembl chr14:14,151,750...14,173,499

G

family with sequence similarity 162, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM162B mRNA

NCBI chr10:51,461,510...51,466,686
Ensembl chr10:51,461,512...51,466,613

G

family with sequence similarity 169, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM169B mRNA

NCBI chr 7:67,923,587...68,012,837
Ensembl chr 7:67,923,587...68,012,840

G

family with sequence similarity 181, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM181B mRNA

NCBI chr 7:92,729,087...92,730,929
Ensembl chr 7:92,729,073...92,731,074

G

family with sequence similarity 53, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM53B mRNA

NCBI chr 7:132,313,813...132,429,518
Ensembl chr 7:132,313,811...132,415,615

G

family with sequence similarity 76, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM76A mRNA

NCBI chr 4:132,626,524...132,649,849
Ensembl chr 4:132,626,524...132,649,869

G

fatty acid synthase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA

NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373

G

fibulin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBLN1 mRNA

NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736

G

F-box protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBXO5 mRNA

NCBI chr10:5,749,155...5,755,465
Ensembl chr10:5,749,160...5,755,600

G

flap structure specific endonuclease 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FEN1 mRNA

NCBI chr19:10,176,496...10,181,757
Ensembl chr19:10,176,496...10,181,533

G

fibrinogen alpha chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGA mRNA

NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934

G

fibroblast growth factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF1 mRNA

NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525

G

fibroblast growth factor 9

increases expression
increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA
dibenz[a,h]anthracene increases expression of FGF9 mRNA in lung epithelial cell

CTD
RGD

PMID:19358281 PMID:19358281

NCBI chr14:58,308,543...58,350,311
Ensembl chr14:58,308,004...58,350,177

G

fibroblast growth factor receptor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGFR3 mRNA

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

fibrinogen gamma chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGG mRNA

NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356

G

fibrinogen-like protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGL2 mRNA

NCBI chr 5:21,577,671...21,583,384
Ensembl chr 5:21,577,640...21,583,372

G

four and a half LIM domains 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FHL1 mRNA

NCBI chr X:55,776,569...55,838,704
Ensembl chr X:55,777,147...55,838,706

G

fin bud initiation factor homolog (zebrafish)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FIBIN mRNA

NCBI chr 2:110,191,270...110,193,338
Ensembl chr 2:110,191,262...110,193,528

G

fidgetin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FIGNL1 mRNA

NCBI chr11:11,737,429...11,758,962
Ensembl chr11:11,737,431...11,758,962

G

filamin, beta

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FLNB mRNA

NCBI chr14:14,518,185...14,651,852
Ensembl chr14:14,518,185...14,651,816

G

flavin containing monooxygenase 1

affects expression

1,2,5,6-dibenzanthracene affects the expression of FMO1 mRNA

NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179

G

flavin containing monooxygenase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO2 mRNA

NCBI chr 1:162,701,886...162,726,327
Ensembl chr 1:162,701,886...162,726,295

G

flavin containing monooxygenase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO3 mRNA

NCBI chr 1:162,781,368...162,812,097
Ensembl chr 1:162,781,369...162,812,097

G

flavin containing monooxygenase 5

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FMO5 mRNA

NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598

G

fibronectin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FN1 mRNA

NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359

G

forkhead box A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXA2 mRNA

NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889

G

forkhead box F2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXF2 mRNA

NCBI chr13:31,809,686...31,815,390
Ensembl chr13:31,809,799...31,815,386

G

ferric-chelate reductase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FRRS1 mRNA

NCBI chr 3:116,653,212...116,701,363
Ensembl chr 3:116,653,113...116,701,826

G

frizzled class receptor 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FZD6 mRNA

NCBI chr15:38,869,673...38,901,587
Ensembl chr15:38,869,429...38,901,583

G

glucose-6-phosphate dehydrogenase X-linked

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of G6PD mRNA

NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800

G

growth arrest and DNA-damage-inducible 45 alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GADD45A mRNA

NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441

G

polypeptide N-acetylgalactosaminyltransferase 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GALNT12 mRNA

NCBI chr 4:47,091,894...47,123,058
Ensembl chr 4:47,091,909...47,123,070

G

growth associated protein 43

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GAP43 mRNA

NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014

G

golgi associated RAB2 interactor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GARIN1A mRNA

NCBI chr 6:29,276,298...29,290,684
Ensembl chr 6:29,279,592...29,290,679

G

golgi associated kinase 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GASK1B mRNA

NCBI chr 3:79,791,795...79,853,585
Ensembl chr 3:79,791,840...79,853,587

G

GATA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GATA2 mRNA

NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014

G

guanylate binding protein 11

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP11 mRNA

NCBI chr 5:105,470,892...105,494,342
Ensembl chr 5:105,470,908...105,494,338

G

guanylate binding protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP4 mRNA

NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970

G

guanylate binding protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP5 mRNA

NCBI chr 3:142,202,695...142,228,105
Ensembl chr 3:142,199,739...142,228,105

G

guanylate-binding protein 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP6 mRNA

NCBI chr 5:105,224,331...105,258,255
Ensembl chr 5:105,225,496...105,287,405

G

glucokinase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of GCK mRNA

NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081

G

ganglioside-induced differentiation-associated-protein 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDAP10 mRNA

NCBI chr12:32,874,115...32,876,918

G

growth differentiation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA

NCBI chr 8:70,768,425...70,784,242
Ensembl chr 8:70,768,425...70,784,242
Ensembl chr 8:70,768,425...70,784,242

G

growth differentiation factor 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDF15 mRNA

NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDPD5 mRNA

NCBI chr 7:99,027,976...99,111,082
Ensembl chr 7:99,030,621...99,111,084

G

gliomedin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GLDN mRNA

NCBI chr 9:54,193,770...54,249,061
Ensembl chr 9:54,193,770...54,249,070

G

GLIS family zinc finger 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GLIS2 mRNA

NCBI chr16:4,412,217...4,443,076
Ensembl chr16:4,412,577...4,442,788

G

guanine nucleotide binding protein, alpha 14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GNA14 mRNA

NCBI chr19:16,413,031...16,590,706
Ensembl chr19:16,413,126...16,588,184

G

G protein subunit alpha transducin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA

NCBI chr 9:107,551,636...107,556,833
Ensembl chr 9:107,551,673...107,556,911

G

golgi phosphoprotein 3-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GOLPH3L mRNA

NCBI chr 3:95,496,280...95,526,553
Ensembl chr 3:95,496,245...95,526,553

G

GPI-anchored HDL-binding protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPIHBP1 mRNA

NCBI chr15:75,468,479...75,470,062
Ensembl chr15:75,468,477...75,471,330

G

G protein-coupled receptor 146

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPR146 mRNA

NCBI chr 5:139,363,452...139,382,170
Ensembl chr 5:139,363,452...139,382,170

G

G protein-coupled receptor 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPR162 mRNA

NCBI chr 6:124,835,407...124,840,900
Ensembl chr 6:124,835,407...124,840,946

G

G protein-coupled receptor, family C, group 5, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPRC5B mRNA

NCBI chr 7:118,571,263...118,594,434
Ensembl chr 7:118,571,270...118,594,434

G

GPRIN family member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPRIN3 mRNA

NCBI chr 6:59,317,988...59,403,291
Ensembl chr 6:59,324,211...59,403,279

G

glutathione peroxidase 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPX7 mRNA

NCBI chr 4:108,257,414...108,263,910
Ensembl chr 4:108,257,587...108,264,158

G

gene regulated by estrogen in breast cancer protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREB1 mRNA

NCBI chr12:16,720,616...16,851,395
Ensembl chr12:16,720,616...16,850,887

G

gremlin 2, DAN family BMP antagonist

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREM2 mRNA

NCBI chr 1:174,661,352...174,749,386
Ensembl chr 1:174,661,351...174,749,385

G

gastrin releasing peptide

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GRP mRNA

NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667

G

glutathione S-transferase, mu 1

multiple interactions

GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione]

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

glutathione S-transferase, pi 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GSTP1 mRNA

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

glutathione S-transferase, pi 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GSTP2 mRNA

NCBI chr19:4,090,288...4,092,221
Ensembl chr19:4,090,285...4,096,023

G

G two S phase expressed protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GTSE1 mRNA

NCBI chr15:85,743,928...85,760,774
Ensembl chr15:85,743,946...85,760,774

G

guanylate cyclase 1, soluble, alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GUCY1A2 mRNA

NCBI chr 9:3,532,349...3,905,791
Ensembl chr 9:3,532,778...3,894,736

G

H1.2 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F2 mRNA

NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350

G

H1.5 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F5 mRNA

NCBI chr13:21,964,002...21,964,795
Ensembl chr13:21,964,053...21,964,795

G

histocompatibility 2, K region locus 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2-K2 mRNA

NCBI chr17:34,193,633...34,197,765
Ensembl chr17:34,194,050...34,197,764
Ensembl chr17:34,194,050...34,197,764

G

histocompatibility 2, Q region locus 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2-Q8 mRNA

NCBI chr17:35,737,710...35,742,945

G

H2A clustered histone 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC10 mRNA

NCBI chr13:23,718,045...23,718,548
Ensembl chr13:23,718,076...23,718,474

G

H2A clustered histone 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC12 mRNA

NCBI chr13:22,219,292...22,219,813
Ensembl chr13:22,219,334...22,219,738

G

H2A clustered histone 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC20 mRNA

NCBI chr 3:96,127,728...96,128,209
Ensembl chr 3:96,127,677...96,128,196

G

H2A clustered histone 22

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC11 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of H2AC22 mRNA

NCBI chr13:21,970,944...21,971,418
Ensembl chr13:21,970,996...21,971,388

G

H2A clustered histone 23

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC23 mRNA

NCBI chr13:21,994,537...21,995,088
Ensembl chr13:21,994,635...21,995,114

G

H2A clustered histone 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC4 mRNA

NCBI chr13:23,935,061...23,935,577
Ensembl chr13:23,935,109...23,935,581

G

H2A clustered histone 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC15 mRNA

NCBI chr13:23,867,456...23,867,942
Ensembl chr13:23,865,450...23,867,931

G

H2A.X variant histone

increases expression

1,2,5,6-dibenzanthracene metabolite results in increased expression of H2AX protein

NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374

G

H2B clustered histone 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2BC14 mRNA

NCBI chr13:21,938,246...21,938,723
Ensembl chr13:21,938,293...21,938,673

G

hepcidin antimicrobial peptide

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAMP mRNA

NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457

G

hyaluronan and proteoglycan link protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAPLN1 mRNA

NCBI chr13:89,688,654...89,759,951
Ensembl chr13:89,687,915...89,759,771

G

hemolytic complement

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HC mRNA

NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450

G

histone deacetylase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HDAC1 mRNA

NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506

G

HEAT repeat containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HEATR1 mRNA

NCBI chr13:12,410,256...12,453,774
Ensembl chr13:12,409,908...12,455,170

G

hephaestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEPH mRNA

NCBI chr X:95,499,042...95,618,091
Ensembl chr X:95,498,965...95,618,091

G

hect domain and RLD 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HERC6 mRNA

NCBI chr 6:57,557,977...57,642,121
Ensembl chr 6:57,557,985...57,641,617

G

hairy/enhancer-of-split related with YRPW motif-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA

NCBI chr 4:123,127,349...123,143,663
Ensembl chr 4:123,127,349...123,143,668

G

Hedgehog-interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HHIP mRNA

NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635

G

hypermethylated in cancer 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HIC1 mRNA

NCBI chr11:75,052,203...75,059,970
Ensembl chr11:75,055,391...75,060,345

G

hypoxia inducible factor 1, alpha subunit

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HIF1A mRNA

PMID:17690111 PMID:19502547

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

hypoxia inducible lipid droplet associated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HILPDA mRNA

NCBI chr 6:29,272,487...29,275,448
Ensembl chr 6:29,272,487...29,275,445

G

hexokinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HK1 mRNA

NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687

G

hexokinase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HKDC1 mRNA

NCBI chr10:62,218,916...62,259,490
Ensembl chr10:62,218,916...62,258,270

G

hepatic leukemia factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HLF mRNA

NCBI chr11:90,227,361...90,281,745
Ensembl chr11:90,227,362...90,281,721

G

high mobility group box 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB2 mRNA

NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033

G

high mobility group box 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB3 mRNA

NCBI chr X:70,599,523...70,604,261
Ensembl chr X:70,599,524...70,604,282

G

3-hydroxy-3-methylglutaryl-Coenzyme A reductase

decreases expression
multiple interactions

1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA

PMID:16269432 PMID:17690111

NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444

G

high mobility group nucleosomal binding domain 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGN2 mRNA

NCBI chr 4:133,692,050...133,695,302
Ensembl chr 4:133,692,049...133,695,961

G

high-mobility group nucleosomal binding domain 2-like 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGN2L6 mRNA

NCBI chr X:140,644,095...140,653,500
Ensembl chr X:140,653,131...140,653,397

G

histamine N-methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HNMT mRNA

NCBI chr 2:23,892,923...23,939,756
Ensembl chr 2:23,892,922...23,939,406

G

homer scaffolding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOMER2 mRNA

NCBI chr 7:81,250,229...81,356,673
Ensembl chr 7:81,250,229...81,357,275

G

hook microtubule tethering protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOOK2 mRNA

NCBI chr 8:85,715,402...85,729,981
Ensembl chr 8:85,717,232...85,729,978

G

hydroxyprostaglandin dehydrogenase 15 (NAD)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HPGD mRNA

NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of HSD11B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HSD11B1 mRNA

NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383

G

heat shock protein 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA1A mRNA

NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132

G

heat shock protein 4 like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA4L mRNA

NCBI chr 3:40,698,664...40,750,538
Ensembl chr 3:40,699,814...40,750,538

G

heat shock 105kDa/110kDa protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPH1 mRNA

NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841

G

hormonally upregulated Neu-associated kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HUNK mRNA

NCBI chr16:90,182,550...90,296,443
Ensembl chr16:90,182,901...90,296,441

G

HYDIN, axonemal central pair apparatus protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HYDIN mRNA

NCBI chr 8:110,993,600...111,336,885
Ensembl chr 8:110,993,609...111,336,885

G

inhibitor of DNA binding 1, HLH protein

multiple interactions
increases expression

[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ID1 mRNA
1,2,5,6-dibenzanthracene results in increased expression of ID1 mRNA

PMID:18711122 PMID:26377693

NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330

G

inhibitor of DNA binding 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ID2 mRNA

NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139

G

immediate early response 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER3 mRNA

NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815

G

immediate early response 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER5 mRNA

NCBI chr 1:154,972,113...154,975,382
Ensembl chr 1:154,972,107...154,975,382

G

interferon, alpha-inducible protein 27 like 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IFI27L2A mRNA

NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939

G

insulin-like growth factor 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of IGF1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF1 mRNA

PMID:16269432 PMID:17690111

NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904

G

insulin-like growth factor I receptor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGF1R mRNA

NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416

G

insulin-like growth factor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF2 mRNA

NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553

G

insulin-like growth factor binding protein 1

increases expression
decreases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of IGFBP1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA

PMID:16269432 PMID:17690111 PMID:26377693

NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546

G

insulin-like growth factor binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IGFBP2 mRNA

NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633

G

insulin-like growth factor binding protein 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP5 mRNA

NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043

G

insulin-like growth factor binding protein 6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP6 mRNA

NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946

G

immunoglobulin heavy chain (J558 family)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IGH-VJ558 mRNA

G

Immunoglobulin heavy chain (gamma polypeptide)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGHG mRNA

G

interferon gamma induced GTPase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IGTP mRNA

NCBI chr11:58,090,382...58,098,418
Ensembl chr11:58,090,382...58,098,417

G

interferon inducible GTPase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IIGP1 mRNA

NCBI chr18:60,506,688...60,525,706
Ensembl chr18:60,509,099...60,525,706

G

IKAROS family zinc finger 4

affects expression

1,2,5,6-dibenzanthracene affects the expression of IKZF4 mRNA

NCBI chr10:128,466,708...128,505,668
Ensembl chr10:128,466,712...128,505,227

G

interleukin 18 receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IL18R1 mRNA

NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014

G

interleukin 4 receptor, alpha

affects expression

1,2,5,6-dibenzanthracene affects the expression of IL4RA mRNA

NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646

G

inverted formin, FH2 and WH2 domain containing

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INF2 mRNA

NCBI chr12:112,555,121...112,581,991
Ensembl chr12:112,555,218...112,581,991

G

inhibin beta-B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INHBB mRNA

NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978

G

inka box actin regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INKA2 mRNA

NCBI chr 3:105,611,915...105,628,158
Ensembl chr 3:105,611,915...105,628,158

G

insulin induced gene 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INSIG2 mRNA

NCBI chr 1:121,232,082...121,260,391
Ensembl chr 1:121,232,082...121,260,318

G

IQ motif containing GTPase activating protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IQGAP3 mRNA

NCBI chr 3:87,989,309...88,028,355
Ensembl chr 3:87,989,278...88,028,355

G

insulin receptor substrate 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRS1 mRNA

NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137

G

Iroquois homeobox 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRX2 mRNA

NCBI chr13:72,771,463...72,782,315
Ensembl chr13:72,776,939...72,782,317

G

integrin beta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITGB4 mRNA

NCBI chr11:115,865,556...115,899,238
Ensembl chr11:115,865,535...115,899,238

G

integral membrane protein 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITM2A mRNA

NCBI chr X:106,440,801...106,446,966
Ensembl chr X:106,440,705...106,446,982

G

inositol 1,4,5-trisphosphate 3-kinase A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ITPKA mRNA

NCBI chr 2:119,572,818...119,581,734
Ensembl chr 2:119,572,818...119,581,744

G

jagged 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAG2 mRNA

NCBI chr12:112,871,439...112,893,437
Ensembl chr12:112,871,439...112,893,396

G

junction adhesion molecule 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAM2 mRNA

NCBI chr16:84,571,011...84,623,268
Ensembl chr16:84,571,011...84,622,816

G

immunoglobulin joining chain

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of JCHAIN mRNA

NCBI chr 5:88,667,663...88,675,667
Ensembl chr 5:88,667,668...88,675,750

G

KN motif and ankyrin repeat domains 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KANK4 mRNA

NCBI chr 4:98,643,129...98,706,295
Ensembl chr 4:98,643,135...98,705,774

G

kazrin, periplakin interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KAZN mRNA

NCBI chr 4:141,829,701...142,801,231
Ensembl chr 4:141,829,701...142,205,056

G

potassium voltage gated channel, Shab-related subfamily, member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNB1 mRNA

NCBI chr 2:166,937,889...167,032,088
Ensembl chr 2:166,937,889...167,032,075

G

potassium voltage-gated channel, Isk-related subfamily, gene 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNE3 mRNA

NCBI chr 7:99,825,714...99,834,076
Ensembl chr 7:99,825,709...99,834,076

G

potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNN2 mRNA

NCBI chr18:45,401,754...45,818,954
Ensembl chr18:45,401,927...45,818,950

G

KCNQ1 overlapping transcript 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KCNQ1OT1 mRNA

NCBI chr 7:142,766,848...142,850,284
Ensembl chr 7:142,731,402...142,850,327

G

potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNS3 mRNA

NCBI chr12:11,140,738...11,201,186
Ensembl chr12:11,140,203...11,201,057

G

potassium channel tetramerisation domain containing 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCTD12 mRNA

NCBI chr14:103,214,017...103,220,073
Ensembl chr14:103,214,017...103,220,073

G

kinesin family member 20A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20A mRNA

NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330

G

kinesin family member 20B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20B mRNA

NCBI chr19:34,899,735...34,953,150
Ensembl chr19:34,899,761...34,953,145

G

kinesin family member 22

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF22 mRNA

NCBI chr 7:126,626,901...126,641,639
Ensembl chr 7:126,626,901...126,641,643

G

kinesin family member 26B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIF26B mRNA

NCBI chr 1:178,356,690...178,766,765
Ensembl chr 1:178,356,690...178,766,765

G

kinesin family member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIFC1 mRNA

NCBI chr17:34,094,640...34,109,607
Ensembl chr17:34,094,633...34,109,635

G

KIT proto-oncogene receptor tyrosine kinase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIT mRNA

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

Kruppel-like transcription factor 13

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLF13 mRNA

NCBI chr 7:63,536,099...63,588,663
Ensembl chr 7:63,536,099...63,588,663

G

kelch-like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLHL5 mRNA

NCBI chr 5:65,264,894...65,325,490
Ensembl chr 5:65,264,882...65,325,531

G

kallikrein related-peptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLK8 mRNA

NCBI chr 7:43,447,001...43,453,250
Ensembl chr 7:43,447,001...43,453,250

G

killer cell lectin-like receptor, subfamily A, member 15

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KLRA15 mRNA

G

killer cell lectin-like receptor, subfamily A, member 16

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KLRA16 mRNA

G

killer cell lectin-like receptor subfamily A, member 22

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KLRA22 mRNA

G

killer cell lectin-like receptor, subfamily A, member 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KLRA4 mRNA

NCBI chr 6:130,020,693...130,044,242
Ensembl chr 6:130,020,694...130,044,234

G

kinetochore-localized astrin/SPAG5 binding

affects expression

1,2,5,6-dibenzanthracene affects the expression of KNSTRN mRNA

NCBI chr 2:118,644,470...118,667,691
Ensembl chr 2:118,644,484...118,684,438

G

keratin 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KRT8 mRNA

NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917

G

keratin associated protein 20-20

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KRTAP20-2 mRNA

NCBI chr16:88,948,027...88,948,191
Ensembl chr16:88,947,974...88,948,438

G

keratin associated protein 6-1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KRTAP6-1 mRNA

NCBI chr16:88,828,587...88,829,180
Ensembl chr16:88,828,587...88,829,180

G

lymphocyte-activation gene 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LAG3 mRNA

NCBI chr 6:124,881,322...124,888,668
Ensembl chr 6:124,881,324...124,888,668

G

laminin, alpha 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA1 mRNA

NCBI chr17:68,004,129...68,129,640
Ensembl chr17:68,004,254...68,129,642

G

laminin, alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA2 mRNA

NCBI chr10:26,857,281...27,493,021
Ensembl chr10:26,856,032...27,495,754

G

laminin, alpha 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA4 mRNA

NCBI chr10:38,841,511...38,986,184
Ensembl chr10:38,841,511...38,986,184

G

lipopolysaccharide binding protein

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of LBP mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of LBP mRNA

NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772

G

left right determination factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEFTY1 mRNA

NCBI chr 1:180,762,587...180,765,966
Ensembl chr 1:180,762,587...180,765,965

G

leptin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEPR mRNA

NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549

G

lectin, galactose binding, soluble 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS1 mRNA

NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665

G

lectin, galactose binding, soluble 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA

NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617

G

lectin, galactose binding, soluble 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS9 mRNA

NCBI chr11:78,853,805...78,875,750
Ensembl chr11:78,853,800...78,875,772

G

galectin like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LGALSL mRNA

NCBI chr11:20,773,355...20,781,916
Ensembl chr11:20,773,576...20,781,056

G

leucine-rich repeat LGI family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGI2 mRNA

NCBI chr 5:52,690,859...52,723,689
Ensembl chr 5:52,690,859...52,723,804

G

LIF receptor alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LIFR mRNA

NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970

G

LIM domain only 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LMO2 mRNA

NCBI chr 2:103,788,309...103,812,223
Ensembl chr 2:103,788,331...103,812,223

G

ligand of numb-protein X 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LNX2 mRNA

NCBI chr 5:146,953,471...147,013,364
Ensembl chr 5:146,953,465...147,013,396

G

lysyl oxidase-like 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LOXL4 mRNA

NCBI chr19:42,580,718...42,601,326
Ensembl chr19:42,582,421...42,601,252

G

lipin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LPIN1 mRNA

NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967

G

lipoprotein lipase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LPL mRNA

NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100

G

lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRAT mRNA

NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280

G

leucine rich repeat and fibronectin type III domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA

NCBI chr 7:30,054,939...30,062,197
Ensembl chr 7:30,054,914...30,062,197

G

leucine rich repeat containing 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRRC36 mRNA

NCBI chr 8:106,140,230...106,190,718
Ensembl chr 8:106,140,203...106,190,718

G

leucine rich repeat containing 75B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRRC75B mRNA

NCBI chr10:75,385,953...75,396,532
Ensembl chr10:75,385,957...75,396,164

G

leukotriene B4 receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTB4R1 mRNA

NCBI chr14:56,002,154...56,005,951
Ensembl chr14:56,003,419...56,005,951

G

latent transforming growth factor beta binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTBP2 mRNA

NCBI chr12:84,829,986...84,923,581
Ensembl chr12:84,829,986...84,923,306

G

leukotriene C4 synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTC4S mRNA

NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443

G

latexin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LXN mRNA

NCBI chr 3:67,365,332...67,371,240
Ensembl chr 3:67,365,331...67,371,259

G

lymphocyte antigen 6 family member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LY6A mRNA

NCBI chr15:74,866,726...74,869,880
Ensembl chr15:74,866,726...74,869,880

G

lymphocyte antigen 6 family member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LY6C1 mRNA

NCBI chr15:74,915,867...74,920,690
Ensembl chr15:74,915,867...74,920,679

G

lymphocyte antigen 6 family member G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LY6G mRNA

NCBI chr15:75,027,110...75,030,977
Ensembl chr15:75,027,089...75,030,975

G

LysM, putative peptidoglycan-binding, domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA

NCBI chr 9:75,532,403...75,545,055
Ensembl chr 9:75,533,023...75,545,053

G

LysM, putative peptidoglycan-binding, domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LYSMD3 mRNA

NCBI chr13:81,805,782...81,820,990
Ensembl chr13:81,805,782...81,820,990

G

lymphatic vessel endothelial hyaluronan receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYVE1 mRNA

NCBI chr 7:110,449,814...110,462,160
Ensembl chr 7:110,449,814...110,462,446

G

MAD2 mitotic arrest deficient-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAD2L1 mRNA

NCBI chr 6:66,512,205...66,518,091
Ensembl chr 6:66,512,374...66,524,204

G

MAD2 mitotic arrest deficient-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MAD2L2 mRNA

NCBI chr 4:148,214,615...148,230,161
Ensembl chr 4:148,214,841...148,230,156

G

MAF bZIP transcription factor B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFB mRNA

NCBI chr 2:160,205,597...160,208,985
Ensembl chr 2:160,205,623...160,208,985

G

v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFF mRNA

NCBI chr15:79,230,813...79,243,278
Ensembl chr15:79,230,821...79,243,276

G

mitogen-activated protein kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP2K6 mRNA

NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348

G

mitogen-activated protein kinase kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA

NCBI chr 4:132,965,290...132,980,240
Ensembl chr 4:132,968,129...132,980,240

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA

NCBI chr 1:39,939,806...40,065,470
Ensembl chr 1:39,940,073...40,065,470

G

microtubule-associated protein tau

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAPT mRNA

NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916

G

myristoylated alanine rich protein kinase C substrate

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARCKS mRNA

NCBI chr10:37,009,239...37,014,922
Ensembl chr10:37,009,371...37,014,916

G

MARVEL (membrane-associating) domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARVELD1 mRNA

NCBI chr19:42,135,879...42,140,137
Ensembl chr19:42,135,839...42,140,142

G

membrane bound O-acyltransferase domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MBOAT1 mRNA

NCBI chr13:30,320,499...30,430,677
Ensembl chr13:30,320,472...30,430,700

G

membrane bound O-acyltransferase domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA

NCBI chr12:24,881,401...25,014,399
Ensembl chr12:24,880,878...25,014,396

G

myeloid cell leukemia sequence 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA

NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487

G

minichromosome maintenance complex component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA

NCBI chr 6:88,860,456...88,875,762
Ensembl chr 6:88,860,456...88,875,762

G

minichromosome maintenance complex component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA

NCBI chr 1:20,873,188...20,890,536
Ensembl chr 1:20,873,192...20,890,536

G

minichromosome maintenance complex component 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM6 mRNA

NCBI chr 1:128,259,312...128,287,442
Ensembl chr 1:128,259,327...128,287,401

G

transformed mouse 3T3 cell double minute 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

G

malic enzyme 1, NADP(+)-dependent, cytosolic

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ME1 mRNA

NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006

G

malic enzyme 3, NADP(+)-dependent, mitochondrial

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ME3 mRNA

NCBI chr 7:89,281,492...89,503,423
Ensembl chr 7:89,281,600...89,503,567

G

multiple EGF-like-domains 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MEGF6 mRNA

NCBI chr 4:154,255,156...154,360,178
Ensembl chr 4:154,255,187...154,360,170

G

O-6-methylguanine-DNA methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGMT mRNA

NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995

G

matrix Gla protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGP mRNA

NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821

G

Mir17 host gene (non-protein coding)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MIR17HG mRNA

NCBI chr14:115,281,822...115,284,160
Ensembl chr14:115,278,211...115,284,162

G

antigen identified by monoclonal antibody Ki 67

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA

NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090

G

MAP kinase-interacting serine/threonine kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA

NCBI chr10:80,501,152...80,512,264
Ensembl chr10:80,501,161...80,513,946

G

melan-A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MLANA mRNA

NCBI chr19:29,674,956...29,685,847
Ensembl chr19:29,675,224...29,686,034

G

monocyte to macrophage differentiation-associated 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MMD2 mRNA

NCBI chr 5:142,549,229...142,594,886
Ensembl chr 5:142,548,113...142,594,555

G

matrix metallopeptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMP8 mRNA

NCBI chr 9:7,558,430...7,568,487
Ensembl chr 9:7,558,457...7,568,486

G

multimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMRN2 mRNA

NCBI chr14:34,097,461...34,126,244
Ensembl chr14:34,097,422...34,126,244

G

meiotic nuclear divisions 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MND1 mRNA

NCBI chr 3:83,995,240...84,063,084
Ensembl chr 3:83,995,240...84,063,093

G

microrchidia 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MORC3 mRNA

NCBI chr16:93,629,009...93,672,964
Ensembl chr16:93,629,009...93,672,961

G

membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPP4 mRNA

NCBI chr 1:59,160,094...59,202,548
Ensembl chr 1:59,160,094...59,202,548

G

Mpv17 transgene, kidney disease mutant-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPV17L mRNA

NCBI chr16:13,721,025...13,767,483
Ensembl chr16:13,721,025...13,767,483

G

myelin protein zero-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MPZL1 mRNA

NCBI chr 1:165,419,745...165,462,144
Ensembl chr 1:165,419,809...165,462,107

G

MAS-related GPR, member E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRGPRE mRNA

NCBI chr 7:143,332,100...143,338,237
Ensembl chr 7:143,332,100...143,338,237

G

myoregulin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRLN mRNA

NCBI chr10:70,040,494...70,055,541
Ensembl chr10:70,040,494...70,055,541

G

membrane-spanning 4-domains, subfamily A, member 4D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MS4A4D mRNA

NCBI chr19:11,514,158...11,535,830
Ensembl chr19:11,514,165...11,535,831

G

mutS homolog 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSH3 mRNA

NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511

G

musashi RNA-binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MSI2 mRNA

NCBI chr11:88,230,208...88,609,197
Ensembl chr11:88,230,208...88,609,339

G

macrophage scavenger receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSR1 mRNA

NCBI chr 8:39,996,284...40,095,790
Ensembl chr 8:40,034,726...40,095,714

G

methylenetetrahydrofolate reductase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTHFR mRNA

NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008

G

myotubularin related protein 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTMR10 mRNA

NCBI chr 7:63,937,443...63,990,556
Ensembl chr 7:63,937,401...63,990,554

G

melatonin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTNR1A mRNA

NCBI chr 8:45,522,144...45,542,270
Ensembl chr 8:45,522,174...45,541,543

G

MTSS I-BAR domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTSS1 mRNA

NCBI chr15:58,813,083...58,955,805
Ensembl chr15:58,813,083...58,953,854

G

musculoskeletal, embryonic nuclear protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MUSTN1 mRNA

NCBI chr14:30,601,214...30,603,567
Ensembl chr14:30,601,157...30,603,567

G

v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MYCN mRNA

NCBI chr12:12,986,094...12,991,837
Ensembl chr12:12,986,094...12,991,915

G

nicotinamide phosphoribosyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NAMPT mRNA

NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348

G

nuclear prelamin A recognition factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NARF mRNA

NCBI chr11:121,128,062...121,146,682
Ensembl chr11:121,128,079...121,146,682

G

N-acetyltransferase 8 (GCN5-related) family member 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NAT8F5 mRNA

NCBI chr 6:85,794,200...85,797,954
Ensembl chr 6:85,794,200...85,797,954

G

non-SMC condensin I complex, subunit D2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPD2 mRNA

NCBI chr 6:125,144,970...125,169,062
Ensembl chr 6:125,144,970...125,168,664

G

non-SMC condensin I complex, subunit H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPH mRNA

NCBI chr 2:126,945,729...126,975,857
Ensembl chr 2:126,945,729...126,975,874

G

neutral cholesterol ester hydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCEH1 mRNA

NCBI chr 3:27,237,153...27,299,112
Ensembl chr 3:27,237,114...27,338,757

G

NDC80 kinetochore complex component

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDC80 mRNA

NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852

G

N-myc downstream regulated gene 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDRG1 mRNA

NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489

G

nuclear paraspeckle assembly transcript 1 (non-protein coding)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NEAT1 mRNA

NCBI chr19:5,874,736...5,895,508
Ensembl chr19:5,874,736...5,897,132

G

nectin cell adhesion molecule 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NECTIN3 mRNA

NCBI chr16:46,208,028...46,318,898
Ensembl chr16:46,208,069...46,318,888

G

nestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NES mRNA

NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758

G

neuroepithelial cell transforming gene 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA

NCBI chr13:3,932,018...3,968,220
Ensembl chr13:3,932,018...3,968,220

G

nuclear factor, interleukin 3, regulated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NFIL3 mRNA

NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109

G

nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NFKBIA mRNA

NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432

G

neuronal guanine nucleotide exchange factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NGEF mRNA

NCBI chr 1:87,404,551...87,501,661
Ensembl chr 1:87,404,556...87,501,592

G

nerve growth factor receptor (TNFR superfamily, member 16)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NGFR mRNA

NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561

G

NHL repeat containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NHLRC2 mRNA

NCBI chr19:56,536,682...56,591,935
Ensembl chr19:56,536,693...56,591,935

G

naked cuticle 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NKD1 mRNA

NCBI chr 8:89,247,961...89,321,515
Ensembl chr 8:89,247,982...89,321,512

G

nicotinamide riboside kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NMRK1 mRNA

NCBI chr19:18,609,380...18,629,555
Ensembl chr19:18,609,314...18,629,792

G

nitric oxide synthase 3, endothelial cell

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOS3 mRNA

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

NADPH oxidase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOX4 mRNA

NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918

G

neuropeptide Y receptor Y1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NPY1R mRNA

NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444

G

NAD(P)H dehydrogenase, quinone 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of NQO1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NQO1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NQO1 mRNA

PMID:17253728 PMID:18711122

NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838

G

nuclear receptor subfamily 1, group D, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR1D2 mRNA

NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642

G

nuclear receptor subfamily 5, group A, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR5A2 mRNA

NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186

G

Notch-regulated ankyrin repeat protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRARP mRNA

NCBI chr 2:25,070,770...25,073,351
Ensembl chr 2:25,070,770...25,073,351

G

neuronal regeneration related protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NREP mRNA

NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082

G

neuregulin 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRG4 mRNA

NCBI chr 9:55,127,506...55,190,937
Ensembl chr 9:55,127,506...55,234,128

G

neurexin I

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRXN1 mRNA

NCBI chr17:90,341,072...91,400,587
Ensembl chr17:90,341,059...91,400,499

G

NSL1, MIS12 kinetochore complex component

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NSL1 mRNA

NCBI chr 1:190,794,710...190,816,755
Ensembl chr 1:190,795,209...190,818,671

G

NUAK family, SNF1-like kinase, 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUAK2 mRNA

NCBI chr 1:132,243,827...132,261,233
Ensembl chr 1:132,243,864...132,261,226

G

nucleoporin 58

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUP58 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUP58 mRNA

NCBI chr14:60,442,733...60,488,951
Ensembl chr14:60,422,061...60,488,880
Ensembl chr14:60,422,061...60,488,880

G

nuclear protein transcription regulator 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUPR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUPR1 mRNA

NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033

G

nucleolar and spindle associated protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA

NCBI chr 2:119,449,205...119,480,646
Ensembl chr 2:119,448,779...119,481,725

G

2'-5' oligoadenylate synthetase 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OAS1A mRNA

NCBI chr 5:121,034,319...121,045,588
Ensembl chr 5:121,034,319...121,045,584

G

ornithine decarboxylase, structural 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ODC1 mRNA

NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506

G

olfactomedin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OLFML1 mRNA

NCBI chr 7:107,166,640...107,190,572
Ensembl chr 7:107,166,653...107,190,301

G

one cut domain, family member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ONECUT1 mRNA

NCBI chr 9:74,769,203...74,796,930
Ensembl chr 9:74,769,203...74,799,063

G

olfactory receptor family 4 subfamily C member 15B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OR4C15B mRNA

NCBI chr 2:89,112,540...89,113,475
Ensembl chr 2:89,110,820...89,118,358

G

olfactory receptor family 52 subfamily AE member 7

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of OR52AE7 mRNA

NCBI chr 7:103,119,248...103,120,198
Ensembl chr 7:103,119,084...103,120,565

G

oxysterol binding protein-like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OSBPL5 mRNA

NCBI chr 7:143,242,499...143,310,745
Ensembl chr 7:143,242,499...143,310,722

G

otopetrin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of OTOP1 mRNA

NCBI chr 5:38,434,748...38,461,560
Ensembl chr 5:38,433,316...38,461,552

G

purinergic receptor P2X, ligand-gated ion channel, 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RX7 mRNA

NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495

G

purinergic receptor P2Y, G-protein coupled 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY1 mRNA

NCBI chr 3:60,910,206...60,916,403
Ensembl chr 3:60,910,216...60,916,403

G

purinergic receptor P2Y, G-protein coupled 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY2 mRNA

NCBI chr 7:100,645,775...100,661,260
Ensembl chr 7:100,645,775...100,662,073

G

phenylalanine hydroxylase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAH mRNA

NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998

G

p21 (RAC1) activated kinase 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAK3 mRNA

NCBI chr X:142,301,370...142,580,792
Ensembl chr X:142,301,587...142,580,792

G

palmdelphin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA

NCBI chr 3:116,711,911...116,762,896
Ensembl chr 3:116,711,907...116,762,636

G

PDZ binding kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PBK mRNA

NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271

G

protocadherin 17

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA

NCBI chr14:84,680,626...84,775,005
Ensembl chr14:84,681,003...84,776,442

G

protocadherin alpha subfamily C, 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHAC2 mRNA

NCBI chr18:37,276,731...37,320,716
Ensembl chr18:37,276,556...37,320,710

G

protocadherin beta 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHB1 mRNA

NCBI chr18:37,397,897...37,400,507
Ensembl chr18:37,397,991...37,400,578

G

protocadherin beta 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA

NCBI chr18:37,606,599...37,609,393
Ensembl chr18:37,606,593...37,609,393

G

proliferating cell nuclear antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCNA mRNA

NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234

G

Purkinje cell protein 4-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCP4L1 mRNA

NCBI chr 1:171,000,833...171,023,837
Ensembl chr 1:171,000,831...171,023,837

G

proprotein convertase subtilisin/kexin type 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCSK4 mRNA

NCBI chr10:80,157,117...80,165,583
Ensembl chr10:80,157,117...80,165,332

G

programmed cell death 6 interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDCD6IP protein

NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327

G

phosphodiesterase 8B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDE8B mRNA

NCBI chr13:95,160,962...95,386,904
Ensembl chr13:95,160,962...95,386,844

G

phosphodiesterase 9A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDE9A mRNA

NCBI chr17:31,605,079...31,695,284
Ensembl chr17:31,605,184...31,695,284

G

platelet-derived growth factor, C polypeptide

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDGFC mRNA

NCBI chr 3:80,943,723...81,121,347
Ensembl chr 3:80,943,723...81,121,347

G

platelet-derived growth factor, D polypeptide

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDGFD mRNA

NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850

G

pyruvate dehydrogenase kinase, isoenzyme 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDK4 mRNA

NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309

G

platelet/endothelial cell adhesion molecule 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PECAM1 mRNA

NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454

G

period circadian clock 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER1 mRNA

NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786

G

period circadian clock 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER2 mRNA

NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046

G

period circadian clock 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER3 mRNA

NCBI chr 4:151,081,475...151,129,167
Ensembl chr 4:151,088,109...151,129,122

G

peroxisomal biogenesis factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PEX26 mRNA

NCBI chr 6:121,160,176...121,175,796
Ensembl chr 6:121,160,626...121,175,796

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PFKFB1 mRNA

NCBI chr X:149,370,441...149,426,874
Ensembl chr X:149,371,225...149,426,874

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PFKFB3 mRNA

NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888

G

pyroglutamyl-peptidase I

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PGPEP1 mRNA

NCBI chr 8:71,099,086...71,113,096
Ensembl chr 8:71,099,085...71,113,038

G

pleckstrin homology like domain, family A, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PHLDA3 mRNA

NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874

G

phosphotyrosine interaction domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PID1 mRNA

NCBI chr 1:84,014,014...84,317,550
Ensembl chr 1:84,014,017...84,341,901

G

piezo-type mechanosensitive ion channel component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIEZO2 mRNA

NCBI chr18:63,143,284...63,520,787
Ensembl chr18:63,143,284...63,520,254

G

phosphoinositide-3-kinase regulatory subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIK3R1 mRNA

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

proviral integration site 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIM1 mRNA

NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086

G

PICALM interacting mitotic regulator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIMREG mRNA

NCBI chr11:71,932,867...71,938,197
Ensembl chr11:71,932,858...71,938,196

G

phosphatidylinositol transfer protein, cytoplasmic 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PITPNC1 mRNA

NCBI chr11:107,098,718...107,361,546
Ensembl chr11:107,098,718...107,361,525

G

protein kinase inhibitor, gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKIG mRNA

NCBI chr 2:163,500,306...163,568,078
Ensembl chr 2:163,500,306...163,568,078

G

pyruvate kinase liver and red blood cell

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKLR mRNA

NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091

G

protein kinase N3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKN3 mRNA

NCBI chr 2:29,967,657...29,981,031
Ensembl chr 2:29,967,696...29,981,034

G

phospholipase C, delta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCD4 mRNA

NCBI chr 1:74,581,175...74,605,137
Ensembl chr 1:74,582,047...74,606,953

G

phospholipase C, gamma 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCG1 mRNA

NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680

G

phospholipase D family member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLD6 mRNA

NCBI chr11:59,674,719...59,678,483
Ensembl chr11:59,674,723...59,678,471

G

pleckstrin homology domain containing, family A member 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHA7 mRNA

NCBI chr 7:115,722,722...115,907,617
Ensembl chr 7:115,722,720...115,907,611

G

pleckstrin homology domain containing, family G (with RhoGef domain) member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHG6 mRNA

NCBI chr 6:125,339,614...125,358,578
Ensembl chr 6:125,339,623...125,357,756

G

perilipin 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PLIN2 mRNA

NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297

G

polo like kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK1 mRNA

NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096

G

polo like kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK2 mRNA

NCBI chr13:110,531,578...110,537,378
Ensembl chr13:110,531,580...110,537,378

G

polo like kinase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK5 mRNA

NCBI chr10:80,192,293...80,201,323
Ensembl chr10:80,192,293...80,201,323

G

phospholipid phosphatase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAP2A mRNA

NCBI chr13:112,937,311...113,004,428
Ensembl chr13:112,937,326...113,004,428

G

phospholipid phosphatase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLPP6 mRNA

NCBI chr19:28,941,320...28,944,201
Ensembl chr19:28,941,353...28,944,211

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PMAIP1 mRNA

NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636

G

patatin-like phospholipase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PNPLA1 mRNA

NCBI chr17:29,077,262...29,109,282
Ensembl chr17:29,077,385...29,109,283

G

proline-rich nuclear receptor coactivator 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PNRC1 mRNA

NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163

G

POC1 centriolar protein A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of POC1A mRNA

NCBI chr 9:106,156,177...106,227,721
Ensembl chr 9:106,158,260...106,227,720

G

podocalyxin-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PODXL mRNA

NCBI chr 6:31,496,428...31,540,872
Ensembl chr 6:31,496,423...31,540,916

G

polymerase (DNA directed), epsilon

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLE mRNA

NCBI chr 5:110,434,185...110,485,319
Ensembl chr 5:110,434,172...110,485,340

G

polymerase (DNA directed), kappa

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLK mRNA

NCBI chr13:96,617,195...96,679,087
Ensembl chr13:96,617,198...96,679,087

G

cytochrome p450 oxidoreductase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POR mRNA

NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180

G

peroxisome proliferator activator receptor delta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPARD mRNA

NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448

G

phosphoribosyl pyrophosphate amidotransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAT mRNA

NCBI chr 5:77,061,096...77,099,425
Ensembl chr 5:77,061,096...77,099,425

G

pro-platelet basic protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPBP mRNA

NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922

G

periplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA

NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285

G

protein phosphatase 1F (PP2C domain containing)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPM1F mRNA

NCBI chr16:16,714,314...16,745,239
Ensembl chr16:16,714,333...16,745,228

G

protein phosphatase 1, regulatory inhibitor subunit 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPP1R2 mRNA

NCBI chr16:31,070,359...31,094,095
Ensembl chr16:31,070,355...31,094,095

G

protein phosphatase 1, regulatory subunit 3C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPP1R3C mRNA

NCBI chr19:36,709,131...36,714,004
Ensembl chr19:36,709,131...36,714,053

G

protein regulator of cytokinesis 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRC1 mRNA

NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007

G

prolylcarboxypeptidase (angiotensinase C)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRCP mRNA

NCBI chr 7:92,524,461...92,583,789
Ensembl chr 7:92,523,678...92,583,791

G

protein C receptor, endothelial

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROCR mRNA

NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391

G

protein S (alpha)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROS1 mRNA

NCBI chr16:62,674,670...62,749,709
Ensembl chr16:62,674,670...62,749,709

G

proline rich 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRR36 mRNA

NCBI chr 8:4,259,478...4,267,530
Ensembl chr 8:4,259,543...4,267,459

G

proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRRG3 mRNA

NCBI chr X:71,005,769...71,016,328
Ensembl chr X:71,006,230...71,016,328

G

serine protease 23

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRSS23 mRNA

NCBI chr 7:89,156,988...89,176,399
Ensembl chr 7:89,156,991...89,176,395

G

serine protease 44

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRSS44 mRNA

NCBI chr 9:110,642,987...110,647,067
Ensembl chr 9:110,643,062...110,653,591

G

pregnancy specific beta-1-glycoprotein 16

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PSG16 mRNA

NCBI chr 7:16,807,938...16,867,375
Ensembl chr 7:16,807,965...16,867,375

G

prostaglandin I2 (prostacyclin) synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTGIS mRNA

NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524

G

prostaglandin reductase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of PTGR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PTGR1 mRNA

NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119

G

protein tyrosine phosphatase 4a1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTP4A1 mRNA

NCBI chr 1:30,979,384...30,988,838
Ensembl chr 1:30,979,383...30,988,390
Ensembl chr 1:30,979,383...30,988,390

G

protein tyrosine phosphatase, non-receptor type 9

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PTPN9 mRNA

NCBI chr 9:56,902,252...56,970,092
Ensembl chr 9:56,902,207...56,970,091

G

protein tyrosine phosphatase receptor type G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRG mRNA

NCBI chr14:10,227,722...10,916,341
Ensembl chr14:10,227,722...10,916,220

G

protein tyrosine phosphatase receptor type R

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRR mRNA

NCBI chr10:115,854,093...116,110,837
Ensembl chr10:115,854,118...116,110,837

G

pentraxin related gene

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTX3 mRNA

NCBI chr 3:66,127,308...66,133,227
Ensembl chr 3:66,127,331...66,133,226

G

PWWP domain containing 4B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PWWP4B mRNA

NCBI chr X:72,180,829...72,193,071
Ensembl chr X:72,180,838...72,193,056

G

peroxisomal membrane protein 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PXMP4 mRNA

NCBI chr 2:154,427,678...154,445,592
Ensembl chr 2:154,427,678...154,445,628

G

RAB38, member RAS oncogene family

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAB38 mRNA

NCBI chr 7:88,079,481...88,140,780
Ensembl chr 7:88,079,481...88,140,780

G

Rac GTPase-activating protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RACGAP1 mRNA

NCBI chr15:99,518,377...99,549,504
Ensembl chr15:99,518,377...99,549,537

G

RAD51 recombinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD51 mRNA

NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926

G

RAD52 homolog, DNA repair protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA

NCBI chr 6:119,878,781...119,899,789
Ensembl chr 6:119,879,659...119,899,789

G

retinoic acid early transcript 1E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAET1E mRNA

NCBI chr10:22,034,441...22,059,820
Ensembl chr10:22,034,468...22,250,038

G

retinoic acid induced 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAI2 mRNA

NCBI chr X:160,500,032...160,562,490
Ensembl chr X:160,500,065...160,562,492

G

receptor (calcitonin) activity modifying protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAMP3 mRNA

NCBI chr11:6,608,507...6,627,478
Ensembl chr11:6,608,521...6,627,475

G

Rap guanine nucleotide exchange factor (GEF) 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAPGEF4 mRNA

NCBI chr 2:71,811,559...72,087,818
Ensembl chr 2:71,811,584...72,087,818

G

RASD family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASD2 mRNA

NCBI chr 8:75,940,572...75,950,741
Ensembl chr 8:75,940,572...75,950,741

G

RasGEF domain family, member 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RASGEF1B mRNA

NCBI chr 5:99,365,279...99,400,786
Ensembl chr 5:99,365,285...99,876,924

G

RAS protein-specific guanine nucleotide-releasing factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRF2 mRNA

NCBI chr13:92,028,526...92,268,584
Ensembl chr13:92,028,519...92,268,164

G

RAS, guanyl releasing protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA

NCBI chr17:75,742,849...75,836,049
Ensembl chr17:75,742,891...75,836,049

G

RNA binding motif protein 47

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RBM47 mRNA

NCBI chr 5:66,173,892...66,309,297
Ensembl chr 5:66,173,892...66,330,461

G

regulator of calcineurin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCAN1 mRNA

NCBI chr16:92,188,839...92,263,057
Ensembl chr16:92,188,841...92,267,755

G

RCSD domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCSD1 mRNA

NCBI chr 1:165,476,503...165,537,632
Ensembl chr 1:165,474,085...165,537,326

G

RecQ protein-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RECQL mRNA

NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813

G

receptor accessory protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA

NCBI chr 6:71,684,413...71,787,694
Ensembl chr 6:71,684,545...71,787,694

G

refilin B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RFLNB mRNA

NCBI chr11:75,910,020...75,918,608
Ensembl chr11:75,910,020...75,918,608

G

regulator of cell cycle

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGCC mRNA

NCBI chr14:79,526,190...79,539,075
Ensembl chr14:79,526,196...79,539,085

G

regulator of G-protein signaling 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS12 mRNA

NCBI chr 5:35,106,273...35,196,988
Ensembl chr 5:35,106,789...35,196,988

G

regulator of G-protein signaling 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS3 mRNA

NCBI chr 4:62,478,079...62,621,256
Ensembl chr 4:62,478,084...62,622,238

G

regulator of G-protein signaling 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS5 mRNA

NCBI chr 1:169,483,070...169,523,367
Ensembl chr 1:169,483,070...169,523,382

G

ras homolog family member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOB mRNA

NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009

G

ras homolog family member C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA

PMID:22579512 PMID:26377693

NCBI chr 3:104,696,350...104,701,775
Ensembl chr 3:104,695,691...104,701,775

G

ras homolog family member U

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RHOU mRNA

NCBI chr 8:124,380,609...124,390,622
Ensembl chr 8:124,380,668...124,390,623

G

ribonuclease, RNase A family, 2A (liver, eosinophil-derived neurotoxin)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNASE2A mRNA

NCBI chr14:51,492,718...51,493,569
Ensembl chr14:51,492,719...51,493,569

G

ribonuclease H2, subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNASEH2B mRNA

NCBI chr14:62,569,517...62,610,445
Ensembl chr14:62,530,038...62,610,441

G

Rho family GTPase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RND1 mRNA

NCBI chr15:98,567,086...98,575,342
Ensembl chr15:98,561,302...98,575,342

G

ring finger protein 125

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF125 mRNA

NCBI chr18:21,077,672...21,120,416
Ensembl chr18:21,077,682...21,116,919

G

ring finger protein 128

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF128 mRNA

NCBI chr X:138,464,089...138,573,894
Ensembl chr X:138,464,065...138,573,894

G

ring finger protein 144A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF144A mRNA

NCBI chr12:26,356,796...26,465,296
Ensembl chr12:26,350,963...26,465,253

G

ring finger protein 167

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF167 mRNA

NCBI chr11:70,538,056...70,542,247
Ensembl chr11:70,538,061...70,542,247

G

ring finger protein 169

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF169 mRNA

NCBI chr 7:99,569,461...99,630,537
Ensembl chr 7:99,569,461...99,629,655

G

ring finger protein 186

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF186 mRNA

NCBI chr 4:138,694,430...138,695,676
Ensembl chr 4:138,694,423...138,695,676

G

U1b6 small nuclear RNA

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNU1B6 mRNA

NCBI chr 3:96,367,340...96,367,505
Ensembl chr 3:96,367,340...96,367,505

G

U2 small nuclear RNA 10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNU2 mRNA

NCBI chr11:101,549,064...101,549,250
Ensembl chr11:101,549,064...101,549,254

G

roundabout guidance receptor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ROBO2 mRNA

NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,889,765

G

ribosomal protein L39-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RPL39L mRNA

NCBI chr16:9,988,061...9,992,775
Ensembl chr16:9,988,090...9,992,775

G

ribosomal protein S27-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RPS27L mRNA

NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798

G

Ras-related associated with diabetes

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of RRAD mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of RRAD mRNA

NCBI chr 8:105,354,702...105,357,921
Ensembl chr 8:105,354,702...105,357,959

G

ribonucleotide reductase M1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM1 mRNA

NCBI chr 7:102,090,902...102,118,978
Ensembl chr 7:102,090,902...102,118,978

G

ribonucleotide reductase M2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM2 mRNA

NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145

G

RRN3 RNA polymerase I transcription factor homolog (yeast)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRN3 mRNA

NCBI chr16:13,598,563...13,632,705
Ensembl chr16:13,598,572...13,632,703

G

arginine/serine rich protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RSRP1 mRNA

NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982

G

retrotransposon Gag like 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL6 mRNA

NCBI chr15:84,437,599...84,442,024
Ensembl chr15:84,437,599...84,442,024

G

retrotransposon Gag like 8A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL8A mRNA

NCBI chr X:52,644,455...52,645,730
Ensembl chr X:52,644,455...52,645,649

G

retrotransposon Gag like 8B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL8B mRNA

NCBI chr X:52,671,132...52,672,404
Ensembl chr X:52,671,144...52,672,375

G

retrotransposon Gag like 8C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL8C mRNA

NCBI chr X:52,609,889...52,611,102
Ensembl chr X:52,609,999...52,610,399

G

RUN and FYVE domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RUFY3 mRNA

NCBI chr 5:88,711,305...88,799,276
Ensembl chr 5:88,712,899...88,799,251

G

S100 calcium binding protein A10 (calpactin)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A10 mRNA

NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950

G

S100 calcium binding protein A14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A14 mRNA

NCBI chr 3:90,434,156...90,436,144
Ensembl chr 3:90,434,163...90,436,144

G

SAC3 domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAC3D1 mRNA

NCBI chr19:6,166,025...6,168,689
Ensembl chr19:6,166,030...6,168,680

G

sterile alpha motif domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAMD5 mRNA

NCBI chr10:9,138,205...9,551,670
Ensembl chr10:9,400,709...9,550,952

G

spermidine/spermine N1-acetyl transferase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SAT1 mRNA

NCBI chr X:153,996,128...153,999,345
Ensembl chr X:153,996,128...153,999,445

G

stearoyl-Coenzyme A desaturase 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SCD mRNA

NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303

G

secretoglobin, family 3A, member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCGB3A1 mRNA

NCBI chr11:49,554,422...49,555,945
Ensembl chr11:49,554,437...49,555,945

G

sodium channel, voltage-gated, type I, beta

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN1B mRNA

NCBI chr 7:30,815,949...30,826,436
Ensembl chr 7:30,815,949...30,826,428

G

sodium channel, voltage-gated, type III, beta

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN3B mRNA

NCBI chr 9:40,180,512...40,202,914
Ensembl chr 9:40,180,513...40,202,914

G

signal peptide, CUB domain, EGF-like 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA

NCBI chr17:28,361,074...28,393,825
Ensembl chr17:28,361,115...28,393,828

G

selenoprotein I

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SELENOI mRNA

NCBI chr 5:30,437,579...30,477,428
Ensembl chr 5:30,437,579...30,477,425

G

sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SEMA3C mRNA

NCBI chr 5:17,779,814...17,935,266
Ensembl chr 5:17,779,279...17,935,266

G

sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SEMA3G mRNA

NCBI chr14:30,939,830...30,952,309
Ensembl chr14:30,939,817...30,952,309

G

stress-associated endoplasmic reticulum protein family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERP2 mRNA

NCBI chr14:76,770,252...76,794,518
Ensembl chr14:76,770,254...76,794,329

G

serine (or cysteine) peptidase inhibitor, clade A, member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA1A mRNA

NCBI chr12:103,819,554...103,829,878
Ensembl chr12:103,819,848...103,829,821

G

serine (or cysteine) peptidase inhibitor, clade A, member 1C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA1C mRNA

NCBI chr12:103,861,185...103,871,209
Ensembl chr12:103,861,185...103,871,146

G

serine (or cysteine) peptidase inhibitor, clade A, member 1D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA1D mRNA

NCBI chr12:103,729,846...103,739,892
Ensembl chr12:103,729,853...103,739,851

G

serine (or cysteine) peptidase inhibitor, clade A, member 1E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA1E mRNA

NCBI chr12:103,913,190...103,923,156
Ensembl chr12:103,913,190...103,925,234

G

serine (or cysteine) peptidase inhibitor, clade A, member 3B

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of SERPINA3B mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPINA3 mRNA

PMID:17690111 PMID:26377693

NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804

G

serine (or cysteine) peptidase inhibitor, clade A, member 3F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA3F mRNA

NCBI chr12:104,180,803...104,187,388
Ensembl chr12:104,180,803...104,187,388

G

serine (or cysteine) peptidase inhibitor, clade A, member 3G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA3G mRNA

NCBI chr12:104,202,406...104,208,198
Ensembl chr12:104,202,504...104,208,198

G

serine (or cysteine) peptidase inhibitor, clade A, member 3H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA3H mRNA

NCBI chr12:104,214,155...104,220,664
Ensembl chr12:104,216,411...104,219,928
Ensembl chr12:104,216,411...104,219,928

G

serine (or cysteine) peptidase inhibitor, clade A, member 3I

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINA3I mRNA

NCBI chr12:104,229,304...104,235,768
Ensembl chr12:104,229,381...104,235,631

G

serine (or cysteine) peptidase inhibitor, clade B, member 1a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINB1A mRNA

NCBI chr13:33,026,075...33,037,189
Ensembl chr13:33,026,075...33,035,168

G

serine (or cysteine) peptidase inhibitor, clade B, member 6b

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SERPINB6B mRNA

NCBI chr13:33,140,797...33,163,050
Ensembl chr13:33,149,192...33,163,050

G

serine (or cysteine) peptidase inhibitor, clade D, member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SERPIND1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPIND1 mRNA

NCBI chr16:17,149,235...17,161,438
Ensembl chr16:17,149,235...17,161,439

G

serine (or cysteine) peptidase inhibitor, clade E, member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE1 mRNA

NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122

G

serine (or cysteine) peptidase inhibitor, clade E, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE2 mRNA

NCBI chr 1:79,772,038...79,836,382
Ensembl chr 1:79,771,914...79,838,897

G

sestrin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SESN2 mRNA

NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812

G

shugoshin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SGO1 mRNA

NCBI chr17:53,981,814...53,996,432
Ensembl chr17:53,981,814...53,996,361

G

SH3-domain GRB2-like 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SH3GL3 mRNA

NCBI chr 7:81,824,581...81,956,618
Ensembl chr 7:81,823,588...81,956,627

G

Shc SH2-domain binding protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SHCBP1 mRNA

NCBI chr 8:4,785,976...4,829,549
Ensembl chr 8:4,785,976...4,829,567

G

siah E3 ubiquitin protein ligase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIAH2 mRNA

NCBI chr 3:58,582,370...58,599,857
Ensembl chr 3:58,582,359...58,599,821

G

sine oculis-related homeobox 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIX1 mRNA

NCBI chr12:73,088,601...73,093,486
Ensembl chr12:73,086,789...73,100,661

G

spindle and kinetochore associated complex subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SKA1 mRNA

NCBI chr18:74,328,370...74,340,889
Ensembl chr18:74,328,370...74,340,889

G

solute carrier family 10, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC10A2 mRNA

NCBI chr 8:5,133,219...5,155,287
Ensembl chr 8:5,133,219...5,155,351

G

solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC13A2 mRNA

NCBI chr11:78,288,102...78,313,107
Ensembl chr11:78,287,913...78,313,043

G

solute carrier family 13 (sodium/sulfate symporters), member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC13A4 mRNA

NCBI chr 6:35,244,888...35,285,061
Ensembl chr 6:35,244,892...35,285,066

G

solute carrier family 16 (monocarboxylic acid transporters), member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SLC16A1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SLC16A1 mRNA

NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778